University of California, Berkeley

University of California, San Francisco

The University of Hong Kong

Healthcare Investment

Hong Kong SAR

- Managing direct & fund Investments at Nan Fung Group CEO's Office
-  Strategic focus in venture & growth stage life sciences companies in US & Asia
-  2 board seats & 7 board observer seats

Nan Fung Life Sciences

Vice President

Ablaze Pharmaceuticals

Board Observer

Fountain Therapeutics

AccuraGen

Bio-Cancer Treatment International

Board Member

Encodia, Inc.

Vitargent (International) Biotechnology Limited

Hong Kong Life Sciences Society (HKLSS)

Mentor

Omniome Inc.

Assistant Vice President

Navitor Pharmaceuticals

Associate

- Global healthcare public equity portfolio manager at Founder & Chairman's family office
-  Global Sources (NASDAQ: GSOL) was sold to Blackstone for ~US$500m in 2017

Global Sources

Investment Associate

- Closed licensing deal (T2D drug with US$140m in sales) with Hansoh Pharma (3692.HK)

Uni-Bio Science Group 联康生物科技集团

Senior Business Development Analyst

- Silicon Valley biotech startup developing advanced protein therapeutics in ophthalmology

Valitor, Inc.

Project Manager

Norman Tse, CFA